Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015037
Filing Date
2018-10-31
Accepted
2018-10-31 13:36:02
Documents
32
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 241426
2 logo_001.jpg GRAPHIC 3697
3 ex31-1.htm EX-31.1 18007
4 ex31-2.htm EX-31.2 17079
5 ex32-1.htm EX-32.1 9012
  Complete submission text file 0001493152-18-015037.txt   929576

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20180930.xml EX-101.INS 56934
7 XBRL SCHEMA FILE vapa-20180930.xsd EX-101.SCH 12364
8 XBRL CALCULATION FILE vapa-20180930_cal.xml EX-101.CAL 21584
9 XBRL DEFINITION FILE vapa-20180930_def.xml EX-101.DEF 31168
10 XBRL LABEL FILE vapa-20180930_lab.xml EX-101.LAB 93920
11 XBRL PRESENTATION FILE vapa-20180930_pre.xml EX-101.PRE 71330
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 181149650
SIC: 2834 Pharmaceutical Preparations